U.S. markets open in 17 minutes
  • S&P Futures

    3,831.50
    -2.50 (-0.07%)
     
  • Dow Futures

    30,916.00
    -20.00 (-0.06%)
     
  • Nasdaq Futures

    11,807.00
    -1.50 (-0.01%)
     
  • Russell 2000 Futures

    1,737.10
    -4.60 (-0.26%)
     
  • Crude Oil

    99.99
    +0.49 (+0.49%)
     
  • Gold

    1,764.90
    +1.00 (+0.06%)
     
  • Silver

    19.21
    +0.09 (+0.47%)
     
  • EUR/USD

    1.0197
    -0.0073 (-0.71%)
     
  • 10-Yr Bond

    2.7670
    -0.0420 (-1.50%)
     
  • Vix

    27.77
    +0.24 (+0.87%)
     
  • GBP/USD

    1.1914
    -0.0037 (-0.31%)
     
  • USD/JPY

    135.0500
    -0.7920 (-0.58%)
     
  • BTC-USD

    20,121.74
    +729.38 (+3.76%)
     
  • CMC Crypto 200

    435.82
    -4.20 (-0.95%)
     
  • FTSE 100

    7,137.10
    +111.63 (+1.59%)
     
  • Nikkei 225

    26,107.65
    -315.82 (-1.20%)
     

Simulations Plus Reports Third Quarter Fiscal 2021 Financial Results

  • Oops!
    Something went wrong.
    Please try again later.
·8 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Third quarter total revenue increased 4% to $12.8 million, with software revenue up 21%;

Board of Directors announces quarterly dividend of $0.06 per share

LANCASTER, Calif., July 12, 2021--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today reported financial results for its third quarter of fiscal 2021, ended May 31, 2021.

Third Quarter Fiscal 2021 Financial highlights (compared with the corresponding period last fiscal year):

  • Total revenue increased 4% to $12.8 million;

  • Software revenue increased 21% to $8.3 million;

  • Services revenue declined 18% to $4.5 million;

  • Gross profit increased 7% to $10.3 million;

  • Gross margin increased from 78% to 81%;

  • Net income increased 29% to $3.8 million;

  • Diluted earnings per share increased 13% to $0.18 per share.

YTD Financial highlights (compared with the corresponding period last fiscal year):

  • Total revenue increased 14% to $36.6 million;

  • Software revenue increased 32% to $22.3 million;

  • Services revenue declined 6% to $14.3 million;

  • Gross profit increased 20% to $28.8 million;

  • Gross margin increased from 75% to 79%;

  • Net income increased 33% to $9.5 million;

  • Diluted earnings per share increased 18% to $0.46 per share.

Shawn O’Connor, chief executive officer of Simulations Plus, said: "Our software business continued its strong performance during the quarter, with revenues increasing by 21% versus last year as product updates and cross-selling initiatives led to an acceleration in growth rates. However, our overall growth rate was moderated due to a higher than normal number of late quarter project delays and drug development program cancellations in our services business, which has historically had periods of volatility. Despite these delays and cancellations, our services pipeline continued to expand, and backlog grew in the quarter. While these trends are encouraging and support our long-term outlook, the delays in services projects will impact the growth rates for the remainder of our fiscal year, and we now expect full-year revenue growth of 5 to 10%."

Mr. O’Connor concluded, "The accelerating growth of software revenue and leverage in our business model continues to support strong and increasing profitability as demonstrated by our net income for the first nine months of fiscal 2021 already exceeding full-year fiscal 2020 net income. With a strong balance sheet, growing industry adoption of artificial intelligence-based simulation software and outsourced services, and an acceleration in software sales, we believe we are well-positioned for success and continue to target annual revenue growth rates above 15% over the next several years following fiscal 2021."

Quarterly Dividend Declared

The Company’s Board of Directors has declared a cash dividend of $0.06 per share of the Company’s common stock, payable on August 2, 2021, to shareholders of record as of July 26, 2021. The declaration of any future dividends will be determined by the Board of Directors each quarter and will depend on earnings, financial condition, capital requirements, and other factors.

Investor Conference Call

The Company will host a conference call on July 12, 2021, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join 5 to 10 minutes before the scheduled start time. The call will be webcast live and will be available on the Investors page of the Simulations Plus website at https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/. A replay of the webcast will be available on the website approximately one hour following the call.

About Simulations Plus, Inc.

Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries Cognigen, DILIsym Services, and Lixoft, we offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – Except for historical information, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties. Words like "believe," "expect," and "anticipate" mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.

SIMULATIONS PLUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

For the three and nine months ended May 31, 2021 and 2020

Three months ended

Nine months ended

(Unaudited)

(Unaudited)

(in thousands, except per common share amounts)

2021

2020

2021

2020

Revenues

$

12,777

$

12,298

$

36,625

$

32,049

Cost of revenues

2,471

2,666

7,815

7,975

Gross margin

10,306

9,632

28,810

24,074

Operating expenses

Selling, general, and administrative

5,094

5,023

14,960

12,646

Research and development

670

752

2,771

2,026

Total operating expenses

5,764

5,775

17,731

14,672

Income from operations

4,542

3,857

11,079

9,402

Other income (expense)

Interest income

37

5

156

27

Interest expense

(22

)

Change in value of contingent consideration

(121

)

(81

)

(364

)

(81

)

Income/(Loss) on currency exchange

33

(1

)

61

1

Total other income (expense), net

(51

)

(77

)

(169

)

(53

)

Income before provision for income taxes

4,491

3,780

10,910

9,349

Provision for income taxes

(704

)

(844

)

(1,433

)

(2,205

)

Net income

$

3,787

$

2,936

$

9,477

$

7,144

Earnings per share

Basic

$

0.19

$

0.17

$

0.47

$

0.40

Diluted

$

0.18

$

0.16

$

0.46

$

0.39

Weighted-average common shares outstanding

Basic

20,105

17,735

20,014

17,661

Diluted

20,802

18,427

20,750

18,334

Other Comprehensive Income, net of tax

Foreign currency translation adjustments

40

30

36

30

Comprehensive Income

$

3,827

$

2,966

$

9,513

$

7,174

SIMULATIONS PLUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(Audited)

(in thousands, except share and per share amounts)

May 31,

August 31,

ASSETS

2021

2020

Current assets

Cash and cash equivalents

$

58,811

$

49,207

Accounts receivable, net of allowance for doubtful accounts of $100 and $50

12,962

7,422

Revenues in excess of billings

3,883

3,093

Prepaid income taxes

492

970

Prepaid expenses and other current assets

1,602

1,596

Short-term investments

60,948

66,804

Total current assets

138,698

129,092

Long-term assets

Capitalized computer software development costs, net of accumulated amortization of $14,616 and $13,582

7,326

6,087

Property and equipment, net

1,260

438

Operating lease right-of-use assets

1,405

927

Intellectual property, net of accumulated amortization of $6,159 and $5,087

10,826

11,898

Other intangible assets, net of accumulated amortization of $2,054 and $1,642

6,596

7,008

Goodwill

12,921

12,921

Other assets

51

51

Total assets

$

179,083

$

168,422

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities

Accounts payable

$

298

$

351

Accrued payroll and other expenses

2,598

2,251

Income taxes payable

16

Current portion - contracts payable

3,333

2,000

Billings in excess of revenues

127

141

Operating lease liability, current portion

426

463

Deferred revenue

542

300

Total current liabilities

7,340

5,506

Long-term liabilities

Deferred income taxes, net

2,270

2,354

Operating lease liability

980

463

Payments due under contracts payable

3,095

4,064

Total liabilities

13,685

12,387

Commitments and contingencies

Shareholders' equity

Preferred stock, $0.001 par value 10,000,000 shares authorized, no shares issued and outstanding

-

-

Common stock, $0.001 par value and additional paid in capital — 50,000,000 shares authorized, 20,121,040 and 19,923,277 shares issued and outstanding

131,994

128,541

Retained earnings

33,310

27,436

Accumulated other comprehensive income

94

58

Total shareholders' equity

165,398

156,035

Total liabilities and shareholders' equity

$

179,083

$

168,422

View source version on businesswire.com: https://www.businesswire.com/news/home/20210712005740/en/

Contacts

Simulations Plus Investor Relations
Ms. Renee Bouche
661-723-7723
renee@simulations-plus.com

Hayden IR
Mr. Brian Siegel
346-396-8696
brian@haydenir.com